CellSource Co., Ltd.
Monthly KPI Quick Report for October 2026
The average number of processing contracts in August is slightly below the same month last year at 49.1 cases. Blood-derived processing contracts decline for self-pay specialty orthopedic clinics, while hybrid clinics increase. By department, self-pay specialty clinics show 639 cases, hybrid clinics 655 cases, obstetrics/gynecology and beauty show growth. Group 1 decreases by 324 cases; Group 2 shows a substantial increase of 1,133 cases.
Key Figures
- Average number of processing contracts per day: 49.1 cases
- Blood-derived processing contracts for self-pay specialty orthopedic clinics: 638 cases
- Blood-derived processing contracts for hybrid orthopedic clinics: 655 cases
- Group 1 orders: down 324 vs. prior year
- Group 2 orders: up 1,133 vs. prior year
AI要約
Section Heading
This quick report provides the速報 values and commentary for KPI related to contract processing services for August. Overall, the daily average cases are below the previous year, but by department, hybrid orthopedic clinics are increasing and obstetrics/gynecology and beauty are also rising. Group 2 shows a significant increase in contracted cases based on the new KPI. CellSource continues to focus on contract processing in regenerative medicine and expands its management support services for medical institutions.
Second Section Heading
Key trends show Group 1 aiming for stable operations with existing customers, while Group 2 seeks to launch new partner clinics and expand order counts. Total orders in August fluctuate versus the previous year, with notable growth in Group 2. Moving forward, under mid-term plans, we will continue to expand the order base and strengthen the medical institution support framework.
CellSource Co., Ltd.
Company overview · Stock price · Financial data · All IR
